西藏药业 (600211.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(西藏药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 3,134,328,350.182,368,009,918.391,820,236,994.97906,936,646.412,554,609,066.221,958,146,141.991,343,187,984.10656,135,778.33
 营业利润(元) 899,092,953.30954,751,255.42664,461,300.58336,808,266.54464,652,986.13513,832,977.76311,058,111.65197,920,331.83
 利润总额(元) 898,194,826.94954,669,621.35664,236,206.45337,095,424.19463,392,057.70512,635,895.59310,320,683.72197,625,331.40
 净利润(元) 810,244,835.23863,520,088.44599,834,323.17305,515,106.51375,277,494.19446,968,616.30265,192,171.67176,249,968.12
 归属于母公司股东的净利润(元) 800,913,981.92855,341,904.01595,904,757.58303,199,537.33369,808,047.91442,786,023.75262,250,027.50174,668,206.63
盈利能力:
 销售毛利率(%) 95.0595.3495.8095.5694.2694.5394.6394.49
 销售净利率(%) 25.8536.4732.9533.6914.6922.8319.7426.86
 净资产收益率(%) 25.2026.2218.839.87----
 总资产报酬率ROA(%) 19.9020.7214.647.56----
 投入资本回报率ROIC(%) 21.8122.2915.708.2111.1012.797.975.34
营运能力:
 存货周转率(次) 1.471.020.750.37----
 应收账款周转率(次) 5.715.443.152.02----
 总资产周转率(次) 0.720.520.410.21----
偿债能力:
 资产负债率(%) 26.4627.0128.0927.7526.0727.8028.7930.21
 股东权益比率(%) 72.9172.4271.4471.7973.4771.7670.7869.39
 已获利息倍数(倍) -25.64-54.67-49.32-39.71108.9949.2542.0161.54
 流动比率 2.872.722.642.642.642.342.192.03
 速动比率 2.772.612.552.552.532.242.091.92
发展能力:
 营业收入增长率(%) 22.6920.9335.5238.2219.4525.3729.4132.74
 营业利润增长率(%) 93.5085.81113.6170.1780.948.94-6.7912.20
 税后利润增长率(%) 116.5693.17127.2373.5976.995.81-12.0711.13
 净资产增长率(%) 11.0510.0820.9519.3914.508.564.712.06
 总资产增长率(%) 11.909.0919.8315.397.8015.3017.1025.02

前瞻产业研究院